May 6, 2020
Dr. Reddy’s approves NDA, ELYXYBin the U.S.
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Dr.Reddy’s
May 6, 2020
Dr. Reddy’s Laboratories Announces the Launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
July 9, 2019
Dr. Reddy’s Announces the Launch of the Over-the-counter Store Brand Equivalent of Mucinex® D Extended Release Tablets in Two Strengths in the U.S. Market
Dr. Reddy’s Laboratories today announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets